Brief: NextCell Pharma: ProTrans Shows Significant Effect In Diabetes

NextCell Pharma AB

08/09/2020 07:50

Sept 8 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * PROTRANS SHOWS SIGNIFICANT EFFECT IN DIABETES
    * PROTRANS-2 CLINICAL TRIAL MET PRIMARY ENDPOINT
    * PATIENTS TREATED WITH A SINGLE DOSE PROTRANS SHOW A
STATISTICALLY SIGNIFICANT IMPROVED PRESERVATION OF INSULIN
PRODUCTION OVER 12 MONTHS, COMPARED TO PATIENTS TREATED WITH
PLACEBO

Source text for Eikon:  ID:nWkr61fzm3 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))